The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival analysis of patients with early and standard onset colorectal cancer: A single center study.
 
Dhruv Patel
No Relationships to Disclose
 
Catarina Martins Maia
No Relationships to Disclose
 
Michael Lyudmer
No Relationships to Disclose
 
Seda Tolu
No Relationships to Disclose
 
Adel Chergui
No Relationships to Disclose
 
Riya Jayesh Patel
No Relationships to Disclose
 
So Yeon Kim
No Relationships to Disclose
 
Radhika Gali
No Relationships to Disclose
 
Ana Acuna Villaorduna
No Relationships to Disclose
 
Sanjay Goel
Stock and Other Ownership Interests - Johnson and Johnson; Merck; Moderna Therapeutics
Honoraria - Amgen; Merck
Research Funding - BeiGene (Inst); Deciphera (Inst); Dragonfly Therapeutics (Inst); EMD Serono (Inst); PharmaMar (Inst); Takeda (Inst); TLC PharmaChem (Inst)
Patents, Royalties, Other Intellectual Property - I have a patent with a co-inventor, John Mariadason, Ph.D, entitled "Method Of Determining The Sensitivity Of Cancer Cells To EGFR Inhibitors Including Cetuximab, Panitumumab And Erlotinib.", Patent No. 20090258364